基因表現市場規模、佔有率和成長分析：按技術、產品、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球基因表現市場價值為 48.2 億美元，預計到 2025 年將成長至 52 億美元，到 2033 年將成長至 95.2 億美元，在預測期（2026-2033 年）內複合年成長率為 7.88%。

基因表現市場正經歷強勁成長，這主要得益於精準醫療需求的不斷成長和轉錄組學研究的日益普及。定序技術的進步，以及對基因組學和生物技術的投資，是推動市場擴張的關鍵因素。高通量轉錄組學技術和先進分子研究工具的應用正在迅速成長，尤其是在腫瘤學、感染疾病以及藥物研發等領域。人工智慧（AI）的整合進一步增強了基因表現分析，加速了疾病生物標記的識別，並改進了標靶治療。臨床檢查室的自動化定序正在簡化診斷流程，而基於雲端的資訊分析工具和數據分析正在促進創新與合作。然而，高成本、數據解讀的複雜性以及監管方面的挑戰可能會阻礙市場的長期成長。

全球基因表現市場按技術、產品、應用、最終用戶和地區進行細分。依技術分類，可分為微陣列、qPCR、次世代定序（RNA-seq）、Northern印跡和單細胞RNA定序。依產品分類，可分為儀器、試劑和耗材以及軟體。按應用分類，可分為藥物發現、生物標記研究、疾病診斷和農業研究。依最終用戶分類，可分為製藥和生物技術公司、研究機構、合約研究組織（CRO）和醫院。依地區分類，可分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球基因表現市場的成長要素

全球基因表現市場正受到定序技術及其他相關平台進步的顯著推動。靈敏度和通量的提升，以及易用性的增強，使得研究人員和臨床醫生能夠更便捷地進行全面的基因表現研究。隨著這些技術的不斷發展，它們能夠幫助闡明複雜的生物學問題，並檢測細微的表達差異。這種可近性的提高促進了新應用領域的拓展，並導致對試劑、儀器和支援服務的需求增加。此外，隨著這些平台在數據分析和研究工作流程中日益重要，對相關產品和服務的投資也在不斷成長，從而提高了效率並擴大了商業性選擇。

全球基因表現市場中的限制因素

引進和維護先進的基因表現平台和試劑的高成本是小規模機構面臨的主要障礙。這些沉重的經濟負擔會阻礙創新技術的應用，進而可能導致市場滲透和發展速度放緩。因此，許多機構可能會選擇繼續使用現有系統或外包，而不是投資新的解決方案。這種出於經濟限制而不願採用最尖端科技的現象，將對全球基因表現市場產生抑製作用，並限制行業內的進步和創新，直到出現更經濟實惠的選擇。

全球基因表現市場趨勢

全球基因表現市場正呈現單細胞分析顯著擴張的趨勢，這主要得益於對更先進的基因表現調查方法日益成長的需求。基礎研究和應用研究都需要深入了解細胞多樣性，這推動了對精密儀器、檢測組件和先進數據分析工具的投資。這一市場趨勢的關鍵特徵是儀器開發商和軟體供應商之間建立夥伴關係，旨在建立整合的處理流程。這些合作有助於在異質組織中發現新基因，有效整合不同細胞類型和微環境下的表達數據，簡化應用研究流程，並最終推動生物學研究和治療方法的開發。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球基因表現市場規模：依技術分類

• 微陣列
• qPCR
• 次世代定序（RNA-seq）
• Northern印跡法
• 單細胞RNA定序

全球基因表現市場規模：依產品分類

• 裝置
• 試劑和耗材
• 軟體

全球基因表現市場規模：依應用領域分類

• 藥物發現
• 生物標記研究
• 疾病診斷
• 農業研究

全球基因表現市場規模：依最終用戶分類

• 製藥和生物技術公司
• 研究機構
• CRO
• 醫院

全球基因表現市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• Illumina Inc.
• Agilent Technologies
• Roche Diagnostics
• Bio-Rad Laboratories
• QIAGEN NV
• Affymetrix（Thermo Fisher）
• Oxford Nanopore Technologies
• Pacific Biosciences
• 10x Genomics
• NanoString Technologies
• Becton Dickinson
• Fluidigm Corporation
• Luminex Corporation
• Takara Bio
• New England Biolabs
• Meridian Bioscience
• Analytik Jena
• Bioventus
• Lexogen GmbH

結論與建議

Global Gene Expression Market size was valued at USD 4.82 Billion in 2024 and is poised to grow from USD 5.2 Billion in 2025 to USD 9.52 Billion by 2033, growing at a CAGR of 7.88% during the forecast period (2026-2033).

The gene expression market is witnessing robust growth, driven by the rising demand for precision medicine and increased adoption of transcriptomics research. Investments in genomics and biotechnology, along with advancements in sequencing technologies, are key factors propelling market expansion. There is a surge in high-throughput transcriptomic technologies and sophisticated molecular research tools, particularly in fields such as oncology, infectious diseases, and pharmaceutical R&D. The integration of artificial intelligence further enhances gene expression analysis, facilitating the identification of disease biomarkers and improving targeted therapies. Automated sequencing in clinical laboratories streamlines diagnostic processes, while cloud-based informatics tools and data analytics promote innovation and collaboration. However, high costs and complexities in data interpretation, along with regulatory challenges, may hinder long-term market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Expression market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Expression Market Segments Analysis

Global gene expression market is segmented by technology, product, application, end-user, and region. Based on technology, the market is segmented into Microarrays, qPCR, Next-Generation Sequencing (RNA-seq), Northern Blotting, and Single-Cell RNA-seq. Based on product, the market is segmented into instruments, reagents & consumables, and software. Based on application, the market is segmented into drug discovery, biomarker research, disease diagnosis, and agricultural research. Based on end-user, the market is segmented into pharma & biotech, research institutes, CROs, and hospitals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Gene Expression Market

The Global Gene Expression market is significantly driven by advancements in sequencing technologies and other related platforms. Enhanced sensitivity and throughput, coupled with improved usability, have facilitated the execution of comprehensive gene expression studies, making them more accessible for researchers and clinicians alike. As these technologies evolve, they allow for the exploration of intricate biological questions and the detection of subtle expression variations. This growing accessibility fosters expansion into new application areas, leading to heightened demand for reagents, equipment, and support services. Furthermore, as these platforms become integral to data analysis and research workflows, investments in related products and services increase, promoting efficiency and broader commercial options.

Restraints in the Global Gene Expression Market

The high costs associated with acquiring and sustaining advanced gene expression platforms and reagents pose a significant obstacle for smaller institutions. These substantial financial commitments can hinder the adoption of innovative technologies, potentially leading to slower market penetration and development. As a result, many organizations may opt to continue using established systems or turn to outsourcing rather than investing in new solutions. This reluctance to adopt cutting-edge technologies, driven by financial constraints, creates a restraining effect on the global gene expression market until more affordable options become available, limiting progress and innovation within the industry.

Market Trends of the Global Gene Expression Market

The Global Gene Expression market is witnessing a significant trend towards the expansion of single-cell profiling, driven by the increasing demand for enhanced gene expression methodologies. The need for detailed insights into cellular diversity in both fundamental research and translational applications is propelling investments in advanced instrumentation, assay components, and sophisticated informatics tools. This market trend is characterized by collaborative partnerships among instrument developers and software providers, aimed at creating integrated processing pipelines. These collaborations enhance discovery in heterogeneous tissues and facilitate streamlined translational studies by effectively integrating expression data across diverse cell types and microenvironments, ultimately advancing biological research and therapeutic development.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Gene Expression Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Microarrays
• qPCR
• Next-Generation Sequencing (RNA-seq)
• Northern Blotting
• Single-Cell RNA-seq

Global Gene Expression Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Consumables
• Software

Global Gene Expression Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Biomarker Research
• Disease Diagnosis
• Agricultural Research

Global Gene Expression Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharma & Biotech
• Research Institutes
• CROs
• Hospitals

Global Gene Expression Market Size & CAGR (2026-2033)

• North America (Technology, Product, Application, End-User)
  • US
  • Canada
• Europe (Technology, Product, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN NV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Affymetrix (Thermo Fisher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Analytik Jena
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lexogen GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations